Brexit Health Alliance Adds To UK-EU Debate; Medtechs Settle Into Interim Brexit Pace
Executive Summary
The pace of Brexit-related work that impacts the UK medtech industry shows no sign of slowing over the summer. In view of unexpected – uncomfortable for some – recent opinion poll findings, there is unlikely to be a significant change in somewhat febrile UK atmosphere anytime soon. And the future UK medtech regulatory situation still needs close attention.
You may also be interested in...
UK Medtechs Find Common Cause On Brexit In NHS Confed's Health Alliance
The UK has yet to get to the sharp end when it comes to the true effects of Brexit on future policy, trade and regulation, but the medtech industry and the national health-care provider, through the NHS Confederation, are pushing for a progressive and inclusive relationship with EU stakeholders. The Brexit Health Alliance is the latest embodiment of that drive.
German Electromed Industry View Of Brexit: We Can Cope
The German electromedical industry has surveyed it members on the potentially negative impacts of Brexit on business continuity. Findings suggest that the effects will be manageable.
UK Device, IVD Sector Cheered By New Funding Pledge For Accelerated Access Program
UK Government health minister James O'Shaughnessy has delighted local medtech innovators with the promise of a package of funding under the Accelerated Access Review (AAR).